CAR T-cell therapy brings new hope in fight against blood cancer

Hyderabad: As blood cancers continue to rise in India, advances in hemato-oncology particularly CAR T-cell therapy are offering new hope for patients with difficult-to-treat conditions. While cancers of the breast, lung, and mouth dominate public attention, doctors observe a steady rise in patients diagnosed with blood cancers such as leukaemia, lymphoma, and multiple myeloma. Improved diagnostics, increasing life expectancy, and greater awareness contribute to more diagnoses, yet many patients reach hospitals late because early symptoms are ignored.

Unlike many other cancers, blood cancers do not usually present as a visible lump. They affect the blood, bone marrow, and immune system, making them difficult to recognise initially. Persistent fatigue, repeated infections, unexplained fever, swollen lymph nodes, easy bruising, prolonged bleeding, and unexplained weight loss are symptoms that should never be dismissed. A simple blood test followed by timely evaluation by a specialist can detect the disease early when treatment is most effective.

Hemato-oncology combines advanced diagnostics with personalised treatment strategies. Until recently, chemotherapy was considered the mainstay of treatment. While it remains an important option, modern treatment has become far more personalised, incorporating targeted therapies, immunotherapy, stem cell transplantation, and advanced cellular therapies. Among these breakthroughs, CAR T-cell therapy is redefining treatment for aggressive blood cancers.

CAR T-cell therapy modifies the body immune system to combat disease. T-cells, key white blood cells, often fail to recognise cancer cells in blood cancers. In this therapy, doctors collect patient T-cells through a specialised blood procedure, modify them in a laboratory to identify and attack cancer cells, and infuse them back into the bloodstream. Instead of introducing a new drug, the therapy empowers the patient own immune system to fight disease.

This therapy serves as a lifeline for carefully selected patients whose disease returned after standard treatment or failed to respond adequately to chemotherapy. CARE Hospitals in Banjara Hills, Hyderabad, provides comprehensive hemato-oncology services through a multidisciplinary team comprising hemato-oncologists, medical oncologists, transplant specialists, intensivists, transfusion experts, and specialised nurses.

The hospital offers advanced diagnostics, chemotherapy, targeted therapies, immunotherapy, bone marrow transplantation, and CAR T-cell therapy under one roof.